Dr. Scott Kuzdzal received a Ph.D. from the University of California at Riverside. He served as a postdoctoral fellow at the Johns Hopkins University School of Medicine, where he co-founded and directed the Johns Hopkins Center for Biomarker Discovery with Dr. Daniel Chan. In addition to extensive industrial research experience, Dr. Kuzdzal has a strong clinical chemistry background and has directed Toxicology and Therapeutic Drug Monitoring Labs at Johns Hopkins Medical Institutions. He currently serves on the editorial review board of Proteomics and on the Scientific Advisory Board for the Cannabis Science Conference. He has published protein and peptide biomarkers for pancreatic cancer (HIPAP1), Alzheimer’s disease and ovarian cancer using a wide variety of separation and detection methods. Scott has lectured at continuing medical education courses at Johns Hopkins Hospital, George Mason University/INOVA Fairfax Hospital and the NIH, as well as conferences worldwide. Scott currently serves as the Vice President of Marketing at Shimadzu Scientific Instruments.